| Features | |
| Active substance | Bromocriptine |
| Also known as | Bromocriptine mesylate |
| Blood pressure | Can cause hypotension |
| Category | Pharma Grade |
| Chemical name | 2-Bromo-О±-ergocryptine |
| Dosage | 2.5 Mg |
| Dosage (medical) | Typically 1.25 mg to 5 mg daily, depending on the condition being treated |
| Dosage (sports) | Not typically used for athletic performance enhancement |
| Dosage Unit | Tabs |
| ean13 | 1395847472172 |
| Effects | Decreases prolactin levels, helps treat Parkinson's disease, and manages symptoms of hyperprolactinemia |
| FORM | Oral |
| Formula | C32H40BrN5O5 |
| Half-life | Approximately 12 to 14 hours |
| Hepatotoxicity | Low, but liver function monitoring is advised with long-term use |
| Lab Test | Blood prolactin levels for effectiveness monitoring |
| Main action | Dopamine agonist |
| Reference | SPRM019 |
| Side effects | Nausea, headache, dizziness, orthostatic hypotension, and vomiting |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Substance class | Ergot alkaloid derivative |
| Tab Piece | 30 Tabs |
| Trade name | Parlodel, among others |
| Use in sports | Not commonly used in sports |
| Water Retention | Minimal |
| Packing | Blister |